Seaport Therapeutics SPTX
NASDAQ SPTX
$19.12 -0.86 (-4.30%)
At close: Nov 16, 2026 · 4:00 PM EST

Seaport Therapeutics (SPTX) Revenue (2025 - 2026)

Updated

Seaport Therapeutics (SPTX) reported Revenue of $3.9 million for Q3 2026, up 38.9% from $2.81 million a year earlier and up 19.7% from the prior quarter.

Analysis

Seaport Therapeutics (SPTX) Revenue (2025 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Seaport Therapeutics' Revenue came in at $11.81 million; for FY2025, it came in at $11.4 million, up 105.9% from FY2024.

  • By year, Revenue came in at $5.54 million in FY2024.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $3.26 million (Q2 2026), $2.13 million (Q1 2026) and $2.52 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 25.40 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 17.40 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 15.07 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 8.30 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 16.58 Bn
10 Seaport Therapeutics 1.03 Bn 63.31 Mn - 3.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.90 Mn
Jun 30, 2026 3.26 Mn
Mar 31, 2026 2.13 Mn
Dec 31, 2025 2.52 Mn
Sep 30, 2025 2.81 Mn
Jun 30, 2025 2.98 Mn
Mar 31, 2025 3.10 Mn
API Access

Seaport Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=SPTX&period=max&api_key=YOUR_API_KEY